ArticleJournal of controlled release : official journal of the Controlled Release Society2018
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.
Eric M Mastria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it